insights_auto
Why is CERS down 3,64%?
Dive Deeperchevron_right
CERS:NASDAQ
Cerus Corp
USDÂ 2,38
arrow_downward
-3,64%(-0,090) 1D
USDÂ 2,37
arrow_downward
-0,42% (-0,010)todayPre-market
Closed: 30 Sep., 16:00:01 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CERS...
Open
USDÂ 2,49
High
USDÂ 2,49
Low
USDÂ 2,36
Mkt. cap
479,63Â m
Avg. vol.
1,67Â m
Volume
153,00
52-wk high
USDÂ 3,47
52-wk low
USDÂ 1,38
EPS
-USDÂ 0,03
Beta
1,80
Shares outstanding
201,52Â m
No. of employees
268
Open
USDÂ 2,49
High
USDÂ 2,49
Low
USDÂ 2,36
Mkt. cap
479,63Â m
Avg. vol.
1,67Â m
Volume
153,00
52-wk high
USDÂ 3,47
52-wk low
USDÂ 1,38
EPS
-USDÂ 0,03
Beta
1,80
Shares outstanding
201,52Â m
No. of employees
268
News stories
From web sources and news partners
MarketBeat
·
2 uur gelede
Bank of America Corp DE Acquires 868,457 Shares of Cerus Corporation $CERS
AD HOC NEWS
·
8 uur gelede
CERS stock reports USD 63.30 million in Q2 revenue
Profile
Cerus Corporation is an American multinational biotechnology company headquartered in Concord, California that develops and provides a treatment system to pathogen-reduce human blood products for the healthcare industry. Wikipedia
About Cerus Corp
CEO-
Employees268
FoundedSep. 1991
HeadquartersConcord, Kalifornië, Verenigde State van Amerika
SectorMedical device
Websitecerus.com